Clinical Research Directory
Browse clinical research sites, groups, and studies.
Management of Hypokalemia in Intensive Care Patients
Sponsor: Anadolu University
Summary
Hypokalemia is a common electrolyte disorder in critically ill patients and may contribute to substantial morbidity and mortality if inadequately managed. Standardized approaches to hypokalemia management in intensive care units (ICUs) remain limited. This study aimed to develop an expert consensus-based hypokalemia treatment algorithm and to evaluate its implementation with clinical pharmacist involvement in critically ill patients. The study was conducted in the general ICU of a state hospital and consisted of two phases. In the first phase, recommendations derived from current clinical guidelines, relevant literature, and clinical practice were evaluated through a two-round expert consensus process involving specialist physicians and clinical pharmacists with ICU experience. Consensus-based recommendations were used to develop a standardized hypokalemia treatment algorithm. In the second phase, a prospective before-and-after design was used to compare routine ICU care with algorithm-guided hypokalemia management accompanied by clinical pharmacist recommendations. Prespecified outcomes included initiation and timing of potassium replacement therapy, achievement of normokalemia, time to normokalemia, recurrent hypokalemia, treatment-associated hyperkalemia, normokalemia at ICU discharge, and ICU length of stay.
Official title: From Consensus to Clinical Practice: Impact of a Clinical Pharmacist-Supported Hypokalemia Management Algorithm in Critically Ill Patients-A Prospective Controlled Study
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
200
Start Date
2024-09-01
Completion Date
2025-08-01
Last Updated
2026-09-22
Healthy Volunteers
No
Interventions
Implementation of hypokalemia treatment algorithm
Implementation of a protocol-driven hypokalemia treatment algorithm collaboratively guided by a physician and a clinical pharmacist to standardize potassium replacement regimens.
Locations (1)
The study was conducted in a 102-bed general intensive care unit at a state hospital in Eskisehir, Turkey.
Eskişehir, Tepebasi, Turkey (Türkiye)